Exhaled and arterial levels of endothelin-1 are increased and correlate with pulmonary systolic pressure in COPD with pulmonary hypertension
2008

Endothelin-1 Levels in COPD Patients with Pulmonary Hypertension

Sample size: 63 publication 10 minutes Evidence: high

Author Information

Author(s): Carratu Pierluigi, Scoditti Cristina, Maniscalco Mauro, Seccia Teresa Maria, Di Gioia Giuseppe, Gadaleta Felice, Cardone Rosa Angela, Dragonieri Silvano, Pierucci Paola, Spanevello Antonio, Resta Onofrio

Primary Institution: University of Bari, Italy

Hypothesis

The imbalance of endothelin-1 and nitric oxide levels occurs in COPD patients with pulmonary hypertension.

Conclusion

COPD patients with pulmonary hypertension have increased levels of endothelin-1 in both exhaled breath and blood compared to those with COPD only.

Supporting Evidence

  • Increased levels of endothelin-1 were found in exhaled breath and blood of COPD patients with pulmonary hypertension.
  • A good correlation was observed between endothelin-1 levels and pulmonary-artery systolic pressure.
  • FENO levels were significantly lower in COPD patients with pulmonary hypertension compared to those with COPD only.

Takeaway

This study found that patients with a lung disease called COPD and high blood pressure in the lungs have more of a substance called endothelin-1 in their breath and blood, which might be important for their health.

Methodology

The study measured exhaled breath condensate and blood levels of endothelin-1 and nitric oxide in three groups: COPD with pulmonary hypertension, COPD only, and healthy controls.

Potential Biases

Potential influence of other treatments on results, as patients were not under steroid treatment but could have been on other medications.

Limitations

The control group consisted of healthy non-smokers, which may not represent a better control group; pulmonary arterial pressure was evaluated by echocardiography rather than the gold standard.

Participant Demographics

63 subjects: 12 with COPD and pulmonary hypertension, 36 with COPD only, and 15 healthy controls; mostly male participants.

Statistical Information

P-Value

p < 0.0001

Statistical Significance

p < 0.0001

Digital Object Identifier (DOI)

10.1186/1471-2466-8-20

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication